Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.

Johnston TH, Versi E, Howson PA, Ravenscroft P, Fox SH, Hill MP, Reidenberg BE, Corey R, Brotchie JM.

Neuropharmacology. 2018 Mar 15;131:116-127. doi: 10.1016/j.neuropharm.2017.11.046. Epub 2017 Nov 29.

PMID:
29197517
2.

The public health significance of latrines discharging to groundwater used for drinking.

Ravenscroft P, Mahmud ZH, Islam MS, Hossain AKMZ, Zahid A, Saha GC, Zulfiquar Ali AHM, Islam K, Cairncross S, Clemens JD, Islam MS.

Water Res. 2017 Nov 1;124:192-201. doi: 10.1016/j.watres.2017.07.049. Epub 2017 Jul 19.

PMID:
28756221
3.

RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.

Ko WK, Martin-Negrier ML, Bezard E, Crossman AR, Ravenscroft P.

Neurobiol Dis. 2014 Oct;70:138-48. doi: 10.1016/j.nbd.2014.06.013. Epub 2014 Jun 24.

PMID:
24969021
4.

Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit.

Eskow Jaunarajs KL, Standaert DG, Viegas TX, Bentley MD, Fang Z, Dizman B, Yoon K, Weimer R, Ravenscroft P, Johnston TH, Hill MP, Brotchie JM, Moreadith RW.

Mov Disord. 2013 Oct;28(12):1675-82. doi: 10.1002/mds.25625. Epub 2013 Sep 3.

5.

Stable groundwater quality in deep aquifers of Southern Bangladesh: the case against sustainable abstraction.

Ravenscroft P, McArthur JM, Hoque MA.

Sci Total Environ. 2013 Jun 1;454-455:627-38. doi: 10.1016/j.scitotenv.2013.02.071. Epub 2013 Apr 11.

PMID:
23584139
6.

Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.

Kobylecki C, Crossman AR, Ravenscroft P.

Exp Neurol. 2013 Sep;247:476-84. doi: 10.1016/j.expneurol.2013.01.019. Epub 2013 Jan 27.

PMID:
23360800
7.

Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.

Kobylecki C, Hill MP, Crossman AR, Ravenscroft P.

Mov Disord. 2011 Nov;26(13):2354-63. doi: 10.1002/mds.23867. Epub 2011 Sep 23.

PMID:
21953539
8.

Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys.

Fernagut PO, Li Q, Dovero S, Chan P, Wu T, Ravenscroft P, Hill M, Chen Z, Bezard E.

PLoS One. 2010 Nov 22;5(11):e14053. doi: 10.1371/journal.pone.0014053.

9.

Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

Barraud Q, Obeid I, Aubert I, Barrière G, Contamin H, McGuire S, Ravenscroft P, Porras G, Tison F, Bezard E, Ghorayeb I.

PLoS One. 2010 Oct 13;5(10):e13306. doi: 10.1371/journal.pone.0013306.

10.

Migration of As, and (3)H/(3)He ages, in groundwater from West Bengal: Implications for monitoring.

McArthur JM, Banerjee DM, Sengupta S, Ravenscroft P, Klump S, Sarkar A, Disch B, Kipfer R.

Water Res. 2010 Jul;44(14):4171-85. doi: 10.1016/j.watres.2010.05.010. Epub 2010 May 21.

PMID:
20542311
11.

Migration and differentiation of human mesenchymal stem cells in the normal rat brain.

Li JM, Zhu H, Lu S, Liu Y, Li Q, Ravenscroft P, Xu YF, Huang L, Ma CM, Bezard E, Zhao RC, Wang RZ, Qin C.

Neurol Res. 2011 Jan;33(1):84-92. doi: 10.1179/016164110X12670144737819. Epub 2010 May 19.

PMID:
20487599
12.

Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease.

Kobylecki C, Cenci MA, Crossman AR, Ravenscroft P.

J Neurochem. 2010 Jul;114(2):499-511. doi: 10.1111/j.1471-4159.2010.06776.x. Epub 2010 Apr 28.

13.

Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate.

Silverdale MA, Kobylecki C, Hallett PJ, Li Q, Dunah AW, Ravenscroft P, Bezard E, Brotchie JM.

Synapse. 2010 Feb;64(2):177-80. doi: 10.1002/syn.20739. No abstract available.

PMID:
19852073
14.

Arsenic in groundwater: a threat to sustainable agriculture in South and South-east Asia.

Brammer H, Ravenscroft P.

Environ Int. 2009 Apr;35(3):647-54. doi: 10.1016/j.envint.2008.10.004. Epub 2008 Dec 24. Review.

PMID:
19110310
15.

Medically assisted nutrition for palliative care in adult patients.

Good P, Cavenagh J, Mather M, Ravenscroft P.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006274. doi: 10.1002/14651858.CD006274.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD006274.

PMID:
18843710
16.

Do ponds cause arsenic-pollution of groundwater in the Bengal basin? An answer from West Bengal.

Sengupta S, McArthur JM, Sarkar A, Leng MJ, Ravenscroft P, Howarth RJ, Banerjee DM.

Environ Sci Technol. 2008 Jul 15;42(14):5156-64.

PMID:
18754363
17.

Using national health policies to improve access to palliative care medications in the community.

Rowett D, Ravenscroft PJ, Hardy J, Currow DC.

J Pain Symptom Manage. 2009 Mar;37(3):395-402. doi: 10.1016/j.jpainsymman.2008.03.013. Epub 2008 Aug 22. Review.

PMID:
18722748
18.

Medically assisted hydration for palliative care patients.

Good P, Cavenagh J, Mather M, Ravenscroft P.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006273. doi: 10.1002/14651858.CD006273.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD006273.

PMID:
18425944
19.

Striatal histone modifications in models of levodopa-induced dyskinesia.

Nicholas AP, Lubin FD, Hallett PJ, Vattem P, Ravenscroft P, Bezard E, Zhou S, Fox SH, Brotchie JM, Sweatt JD, Standaert DG.

J Neurochem. 2008 Jul;106(1):486-94. doi: 10.1111/j.1471-4159.2008.05417.x. Epub 2008 Jul 1.

20.

Survey of bereavement support provided by Australian palliative care services.

Mather MA, Good PD, Cavenagh JD, Ravenscroft PJ.

Med J Aust. 2008 Feb 18;188(4):228-30.

PMID:
18279130

Supplemental Content

Loading ...
Support Center